-
Signature
-
/s/ Tami Chen, Attorney-in-Fact
-
Stock symbol
-
NTRA
-
Transactions as of
-
Jan 20, 2024
-
Transactions value $
-
-$23,924
-
Form type
-
4
-
Date filed
-
1/23/2024, 09:05 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
NTRA |
Common Stock |
Options Exercise |
|
+191 |
+0.04% |
|
470K |
Jan 20, 2024 |
Direct |
F1 |
transaction |
NTRA |
Common Stock |
Options Exercise |
|
+143 |
+0.03% |
|
470K |
Jan 21, 2024 |
Direct |
F1 |
transaction |
NTRA |
Common Stock |
Sale |
-$8.04K |
-118 |
-0.03% |
$68.16 |
470K |
Jan 22, 2024 |
Direct |
F2 |
transaction |
NTRA |
Common Stock |
Sale |
-$15.9K |
-233 |
-0.05% |
$68.16 |
470K |
Jan 22, 2024 |
Direct |
F3 |
holding |
NTRA |
Common Stock |
|
|
|
|
|
21.2K |
Jan 20, 2024 |
By Caraluna 1 Trust |
F4 |
holding |
NTRA |
Common Stock |
|
|
|
|
|
21.2K |
Jan 20, 2024 |
By Caraluna 2 Trust |
F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
NTRA |
Restricted Stock Unit |
Options Exercise |
$0 |
-191 |
-11.15% |
$0.00 |
1.52K |
Jan 20, 2024 |
Common Stock |
191 |
|
Direct |
F1, F5 |
transaction |
NTRA |
Restricted Stock Unit |
Options Exercise |
$0 |
-143 |
-19.97% |
$0.00 |
573 |
Jan 21, 2024 |
Common Stock |
143 |
|
Direct |
F1, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: